Abstract
The main theme of this volume is the inherited retinal degenerations, but the most important causes of blindness have a different aetiology, not directly related to genetic defects. Diabetes is the greatest cause of blindness in younger people, and even con sidering all age groups is as common a cause of blindness as Glaucoma and Age Related Maculopathy. Diabetes causes a retinopathy (DR) which is basically a vasculopathy1,2 and the cellular biology of DR has been recently linked to cytokines.3 Starting from this fact, it has been proposed that techniques of molecular biology which might be of use in the treatment of inherited degenerative diseases could also be applicable to DR. This paper is however concerned with a far simpler method of controlling DR, which is based on the physiology of the eye, the particular features of which have been known for half a century but not exploited in this connection. The basic idea is that anoxia early in DR will only develop during dark adaptation, occuring in long periods every night in sleep.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
N. Frank, 1986, Diabetic retinopathy: current concepts of evaluation and treatment. Clinics in Endocrinology and Metabolism, 15:933–969.
N. Frank, 1995, Diabetic Retinopathy, In: Progress in Retinal and Eye Research, 14:361–392.
L.P. Aiello, 1997, Vascular Endothelial Growth Factors. 20th-century mechanisms, 21st-century therapies, Invest. Ophthalmol. Vis. Sci. 38:1847–1652.
T.S. Kern and R.L. Engerman, 1996, Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia, Arch. Ophthalmol. 114:306–310.
W.A. Hagins, P.D. Ross, R.L. Tate, and S. Yoshikami, 1989, Transduction heats in retinal rods: Tests of the role of cGMP by pyroelectric calorimetry, Proc. Nat. Acad. Sci. USA. 86:1224–1228.
K.-W. Yau and D.A. Baylor, 1989, Visual Transduction, Annual Rev. Neurosci. 12:289–327.
V.A. Alder, E.S.J. Cringle, and I.J. Constable, 1983, The retinal oxygen profile in Cats, Invest. Ophthalmol. Vis. Sci. 24:30–36.
R.A. Linsenmeier, 1986, The effects of light and darkness on oxygen distribution and consumption in the cat retina, J. Gen. Physiol. 88:521–542.
R.A. Linsenmeier and R.D. Braun, 1992, Oxygen distribution and consumption in the cat retina during normotension and hypoxaemia. J. Gen. Physiol. 99:177–197.
L.M. Haugh, R.A. Linsenmeier, and T.K. Goldstick, 1990, Mathematical Models of the spatial distribution of retinal oxygen tension and consumption, including changes on illumination, Ann. Biomed. Eng. 18:10–36.
J. Ahmed, R.D. Braun, R. Dunn Jr., and R.A. Linsenmeier, 1993, Oxygen distribution in the macaque retina. Invest. Ophthalmol. Vis. Sci. 34:516–521.
R.D. Braun and R.A. Linsenmeier, 1995, Oxygen consumption in the inner and outer retina of the cat, Invest. Ophthalmol. Vis. Sci. 36:542–554.
L.M. Haugh, L.A. Scheidt, E.R. Griff, and R.A. Linsenmeier, 1995, Light evoked oxygen responses in isolated Toad retina, Exp. Eye Res., 61:73–81.
L.J. Frishman, F. Yamamoto, J. Bogucka, and R.H. Steinberg, 1992, Light-evoked changes in [K(+)]0 in proximal portion of light-adapted cat retina, J. Neurophysiol. 67:1201–1212.
R.F. Miller and J.E. Dowling, 1970, Intracellular responses of the Muller (glial) cells of the mudpuppy retina: their relationship to the b-wave of the electroretinogram, J. Neurophysiol. 33:323–341.
E.A. Newman, 1985, Regulation of extracellular potassium by glial cells in the retina, Trends in Neuroscience 8:156–159.
R.A. McFarland, J.N. Evans, and M.H. Halperin, 1941, Ophthalmic aspects of acute oxygen deficiency, Arch Ophthalmol NY. 26:886–913.
J. Mandlebaum, 1941, Dark adaptation; physiologic and clinical considerations Arch. Ophthalmol. 26:203–239.
A.M.P. Hamilton, M.W. Ulbig, and P.J. Polkinghorne, 1996, Management of Diabetic Retinopathy. BMJ press London pp 136.
Diabetic Retinopathy Research Group. Second Report, 1978, Amer. J. Ophthalmol. 85:82–106.
S.E. Simonsen, 1965, Electroretinographic study of diabetics; Preliminary Report, Acta Ophthalmologica, 43:841–843.
T. Amemiya, 1977, Dark adaptation in diabetics. Ophthalmologica, 174:322–326.
D.B. Henson, and R.V. North, 1979. Dark adaptation in diabetes mellitus, Brit J. Ophthalmol. 63:539–541.
M.O. Scase, D.H. Foster, W.P. Honan, J.R. Heron, M.C. Guilliford, and J.H.B. Scarpello, 1990, Abnormalities in hue discrimination with very brief stimuli in diabetic patients, Clin. Vis. Sci. 6:49–57.
K. Frost-Larsen, H.W. Larsen, and S.E. Simonsen, 1981, The value of dark adaptation as a prognostic tool in diabetic retinopathy, Metabolic and Pediatric Ophthalmology, 5:39–44.
E.B. Roeker, E. Pulos, G.H. Bresnick, and M. Severns, 1992, Characterisation of the electroretinographic scotopic b-wave amplitude in diabetic and normal subjects, Invest. Ophthalmol. Vis. Sci. 33:1575–1583.
D.V. De Alwys, J.P. Reffin, S.J. Tregear, L.G. Ripley, and A.G. Caswell, 1993, Should the management of diabetic retinopathy be based on the measurement of visual function rather than observations of retinal morphology? Invest. Ophthalmol. Vis. Sci. 34: ARVO Absts. #80 pg. 719.
V.C. Greenstein, S.R. Thomas, H. Blaustein, K. Koenig, and R.E. Carr, 1993, Effects of early diabetic retinopathy on rod system sensitivity, Optom. Vis. Sci. 70:18–23.
J.V. Lovasik and H. Kergoat, 1993, Electroretinographic results and ocular vascular perfusion in type 1 diabetes, Invest. Ophthalmol. Vis. Sci. 34:1731–1743.
S.D. Tregear, P.J. Knowles, D.V. De Alwys, J.P. Reffin, L.G. Ripley, and A.G. Caswell, 1994, Colour vision deficits predict the development of sight-threatening disease in diabetic subjects with background retinopathy. Invest. Ophthalmol. Vis. Sci. 34;ARVO Absts. =81 pg. 719.
V.C. Greenstein, D.C. Hood, R. Ritch, D. Steinberger, and R.E. Carr, 1989, S(Blue) cone pathway vunerability in Retinitis pigmentosa, Diabetes, and Glaucoma. Invest. Ophthalmol. Vis. Sci. 30:1732–1737.
A. Harris, O. Arend, R.P. Danis, D. Evans, S. Wolf, and B.J. Martin, 1996, Hyperoxia improves contrast sensitivity in early diabetic retinopathy, Brit, J. Ophthalmol. 80:209–213.
F. Dean, A. Dornhorst, and G.B. Arden, 1997. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects, Brit. J. Ophthalmol. 81:27–30.
R.A. Linsenmeier, R.D. Braun, M.A. McRipley, L.B. Padnick, and D.L. Tatchell, 1997. Retinal hypoxia in long term diabetic cats. Invest. Ophthalmol. Vis. Sci. 38: ARVO Abs. S77 #3569.
J.S. Tiedman, S.E. Kirk, and J.M. Beach, Inner retinal oxygen consumption increases during hyperglycaemia in diabetic patients, Invest. Ophthalmol. Vis. Sci. 38: ARVO Abs. S714.
S. Konno, G.T. Feke, A. Yashida, N. Fujio, D.G. Goger, and S.M. Buzney, 1996, Retinal blood flow changes in Type I Diabetes, Invest. Ophthalmol. Vis. Sci. 37:1140–1148.
M.K. v.d. Enden, J.R. Nyengaard, E. Ostrow, J.H. Burgan, and J.R. Williamson, 1995, Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism, Invest. Ophthalmol. Vis. Sci. 36:1675–1685.
G.T. Feke and S.M. Buzney, 1994, Retinal circulatory abnormalities in type 1 diabetes. Invest. Ophthalmol. Vis. Sci. 35:2968–2975.
J. Ditzel, 1979, Changes in red cell oxygen release capacity in diabetes mellitus. Fed. Proc. 38:2484–2488.
W.G. Robison, J.L. Jacot, J.P. Glover, M.D. Basso, and T.C. Hohman, 1997, Aldose reductase Inhibitor intervention after significant diabetic-like capillary basement membrane thickening. Invest. Ophthalmol. Vis. Sci. 38:ARVO Abs S715 #3305.
K.M. Reiser, 1990, Non-enzymatic glycation of collagen in ageing and diabetes, Proc. Soc. Exp. Biol. Med. 196. 17–29.
W.D. Robison, N.M. Laver, and M.F. Lou, 1995, The role of aldose reductase in diabetic retinopathy: prevention and intervention studies, Progress in Retinal and Eye Research, 14:593–641.
G.B. Arden, J.E. Wolf, and Y. Tsang, 1998, Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis, Vision Res. 38:1723–1729.
W.A.H. Rushton, 1963, Increment threshold and dark adaptation, J. Opt. Soc. Amer. 3:104–109.
J. Stone and J. Maslim, 1997, Mechanisms of retinal angiogenesis. Progress in Retinal and Eye Research, 16. 157–181.
H. Tanihara, M. Inatani, and Y. Honda, 1997, Growth factors and their receptors in the retina and pigment epithelium. In Progress in Retinal and Eye Research. 16:271–301.
M.K. Mathews, C. Merges, D.S. McLeod, and G.A. Lutty, 1997, VEGFand vascular permeability changes in human DR, Invest. Ophthalmol. Vis. Sci. 38:2729–2741.
T. Murata, K. Nakagawa, A. Khalil, T. Ishibashi, H. Inomata, and K. Sueshi, 1996, The relation between the expression of VEGF and the breakdown of BRB in diabetic rat retinas, Lab. Invest. 74:819–825.
H. Sone, Y. Kawakami, Y. Okuday, Y. Sekine, S. Honmura, K. Matsuo, T. Seyawa, H. Suzuki, and K. Yamashita, 1997, Ocular VEGF levels in diabetic rats are elevated before observable retinal proliferative changes, Diabetologia, 40:726–730.
R.H. Amin, R.N. Frank, A. Kennedy, D. Eliott, J.E. Puklin, and G.W. Abrams, 1997, VEGF is present in glial cells of the retina and optic nerve of human subjects with non-proliferative diabetic retinopathy, Invest. Ophthalmol. Vis. Sci. 38:38.
J. Ambati. K.V. Chalan, D.K. Chawla, C.T. D’Angio, E.G. Guillet, S.S. Rose, R.E. Vanderlinde, and B.K. Ambati, 1997, Elevated gamma-aminobutyric acid, glutamate and VEGF levels in the vitreous of patients with PDR, Arch. Ophthalmoi. 115:1161–624.
A. Khalik, D. Jarvis, D. McLeod, and D. Boulton, 1996, Oxygen modulates the response of the retinal pigment epithelium to Basic Fibroblast Growth Factor and Epidermal factor by receptor regulation. Invest. Ophthalmol. Vis. Sci. 37:436–443.
V.A. Alder, E.S.J. Cringle, and M. Brown, 1987, The effect of regional retinal photocoagulation on vitreal oxygen tension. Invest. Ophthalmol. Vis. Sci. 28:1078–1085.
C.J. Pournara, M. Tsacopoulos, K. Strommer, N. Gilodi, and P. Leuenberger, 1990, Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiography in miniature pigs. Ophthalmology 97:1329–1333.
M.J. Mosely, S.C. Bayliss, and A.R. Fielder, 1988, Light transmission through the human eyelid: in vivo measurement, Ophthal. Physiol. Opt. 4:229–230.
K. Ando and D.F. Kripke, 1996, Light attenuation by the human eyelid. Biol. Psychiatry, 39:22–25.
J. Robinson, S.C. Bayliss, and A.R. Fielder, 1991, Transmission of light across the adult and neonatal eyelid in vivo, Vision Res. 31:1837–1840.
M.L. Crawford and R.E. Marc, 1976, Light transmission of cat and monkey eyelids, Vision Res. 16:323–324.
J.F. Cooper, 1996, A psychophysical method of measuring the attenuation of retinal illumination in humans caused by closing the eyelids, and the relationship of this to skin albedo. Project report submitted for B.Sc. City University, London,U.K.
W. Spileers, F. Falcao-Reis, C. Hogg, and G.B. Arden, 1993, A new Ganzfeld electroretinographic stimulator powered by red and green LEDs. Clin. Vis. Sci. 8:21–39.
G.B. Arden, J.E. Wolf, T. Berninger, C.R. Hogg, R. Tzekov, and G.E. Holder, 1998, S-cone ERGs elicited by a simple technique in normals and in tritanopes Vision Res. in the press
W.S. Stiles, 1959, Color vision: The approach through increment threshold sensitivity. Proc. Nat. Acad. Sci. 45:100–128.
L. Adams, G.B. Arden, and Joan Behrman, 1969, Responses of human visual cortex following excitation of peripheral rods. Brit. J. Ophthalmol. 53:439–452.
D. Regan, 1972, Evoked Potentials in sensory physiology and clinical medicine, Chapman and Hall, Lond.
G.B. Arden and M. Hall, 1995, Does occupational exposure to Argon laser radiation decrease colour contrast sensitivity in UK Ophthalmologists? Eye, 9:686–696.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Arden, G.B., Wolf, J.E., Collier, J., Wolff, C., Rosenberg, M. (1999). Dark Adaptation is Impaired in Diabetics before Photopic Visual Losses Can be Seen. In: Hollyfield, J.G., Anderson, R.E., LaVail, M.M. (eds) Retinal Degenerative Diseases and Experimental Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-33172-0_29
Download citation
DOI: https://doi.org/10.1007/978-0-585-33172-0_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46193-4
Online ISBN: 978-0-585-33172-0
eBook Packages: Springer Book Archive